Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting

(NASDAQ:VXRT), Company Urges Stockholders to Vote 'FOR' Reverse Stock Split Proposal at Upcoming Annual Meeting to Avoid Nasdaq Delisting Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Support Proposal #2 SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) today announced that it has filed a supplement to its […]

NexGold Infill Drilling Intersects New Zones of Gold Mineralization at the Goldboro Gold Project

(TSX-V:NEXG),(OTC US:NXGCF),(OTCQX:NXGCF), TORONTO, May 16, 2025 (GLOBE NEWSWIRE) — NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company“) is pleased to provide an update on its ongoing 25,000 metre diamond drill program initially announced on January 22, 2025 at the Company's Goldboro Project in Nova Scotia (“Goldboro“). The drill program is primarily designed

DeFi Dev Corp. and BONK Make History with First Public Company and Community Memecoin Validator Partnership

(NASDAQ:DFDV),(NASDAQ:JNVR), BOCA RATON, FL, May 16, 2025 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced a strategic partnership with BONK, the premier community memecoin of the Solana ecosystem with a market capitalization exceeding $1.8 billion and

NextNRG Reports Preliminary April 2025 Revenues up 154% Year-over-Year

(NASDAQ:NXXT), MIAMI, May 16, 2025 (GLOBE NEWSWIRE) — NextNRG, Inc. (Nasdaq: NXXT), a pioneer in AI-driven energy innovation–transforming how energy is produced, managed and delivered through its advanced Utility Operating System, smart microgrid technology, wireless EV charging and on-demand mobile fuel delivery solutions– today announced preliminary unaudited financial results for April 2025. April 2025 Highlights:

Windtree Therapeutics Reports First Quarter 2025 Financial Results and Provides Key Business Updates

(NASDAQ:WINT), WARRINGTON, Pa., May 16, 2025 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early and late-stage innovative therapies for critical conditions, today reported financial results for the first quarter ended March 31, 2025 and provided key business updates.

Winnebago Industries Board of Directors Approves Quarterly Cash Dividend

(NYSE:WGO), EDEN PRAIRIE, Minn., May 16, 2025 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE:WGO), a leading outdoor lifestyle product manufacturer, today announced that the company's Board of Directors approved a quarterly cash dividend of $0.34 per share payable on June 25, 2025, to common stockholders of record at the close of business on June 11,

Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor Day

(NASDAQ:REPL), WOBURN, Mass., May 16, 2025 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that it will host a conference call on Thursday, May 22, 2025 at 8:00 a.m. ET to discuss its financial results for the fiscal fourth quarter and

Spectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference

(TSX:EDT), TORONTO, May 16, 2025 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that management will participate in a fireside chat at the 3rd Annual H.C. Wainwright BioConnect Investor Conference, on Tuesday, May 20, 2025 at 11:30

IZEA Announces Commencement of a Modified Dutch Auction Tender Offer to Repurchase up to $8.7M of its Common Stock

(NASDAQ:IZEA), ORLANDO, Fla., May 16, 2025 (GLOBE NEWSWIRE) — IZEA Worldwide, Inc. (NASDAQ: IZEA), a leading influencer marketing company that makes Creator Economy solutions for marketers, announced today that it has commenced a modified “Dutch auction” tender offer (the “Offer”) to repurchase up to $8,700,000 of its common stock. Under the terms of the Offer,

PharmaTher Announces FDA Extends Review Period for Ketamine; New Approval Goal Date August 9, 2025

(CNSX:PHRM.CN),(OTC US:PHRRF),(Other OTC:PHRRF),(CNSX:PHRM), TORONTO, May 16, 2025 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (“PharmaTher” or the “Company”), a specialty pharmaceutical company focused on ketamine for unmet medical needs, today announced the U.S. Food and Drug Administration (FDA) has extended the approval goal date for the review of its new drug application

Scroll to Top